To include your compound in the COVID-19 Resource Center, submit it here.

Inspire, Merck deal

Merck will acquire ophthalmic company Inspire for $5 per share, or about $430 million in cash. The price is a 26% premium to Inspire's

Read the full 240 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE